Approach Phase 2b trial arm Duration 24 weeks Review Point Week 12 and 24 Notes METAOD006 (OPTIONS) used 24 weeks at oral doses 0.25, 0.5, or 1 mg/day in 502 obese adults
That said, super-intense exercise may tire you out more, so if youre already feeling fatigue, dont push yourself to run the farthest or lift the heaviest you have in a while
Brennand KJ, Simone A, Jou J, Gelboin-Burkhart C, Tran N, Sangar S, et al
Proper injection technique, including rotation of injection sites and allowing the medication to reach room temperature before administration, may help minimize these local reactions
There's no evidence from published research that BPC-157 causes cancer
You can also talk to your healthcare provider about alternative treatments or ways to save